Beijing Tiantan Biological Products Co., Ltd.
600161
Rang în acțiuni
#4319
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Preț acțiune
$1.81
Capitalizare de piață
$3.59B
Schimbare (1 zi)
-0.90%
Schimbare (1 an)
-32.39%
Țară
CN
Tranzacționează Beijing Tiantan Biological Products Co., Ltd. (600161)
Categorie
Healthcare
Raport P/S pentru Beijing Tiantan Biological Products Co., Ltd. (600161)
Raport P/S la data de October 2026 TTM: 4.27
Conform celor mai recente rapoarte financiare și prețului acțiunilor Beijing Tiantan Biological Products Co., Ltd., raportul P/S actual (TTM) este 4.27. La sfârșitul anului 2024, compania avea un P/S de 6.75.
Istoricul raportului P/S pentru Beijing Tiantan Biological Products Co., Ltd. din 2001 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 4.27 | -18.80% |
| 2025 | 5.26 | -22.02% |
| 2024 | 6.75 | -31.59% |
| 2023 | 9.87 | 29.06% |
| 2022 | 7.64 | -2.32% |
| 2021 | 7.83 | -38.14% |
| 2020 | 12.65 | 70.59% |
| 2019 | 7.42 | 52.05% |
| 2018 | 4.88 | -27.59% |
| 2017 | 6.74 | -14.86% |
| 2016 | 7.91 | -11.86% |
| 2015 | 8.98 | 47.94% |
| 2014 | 6.07 | 21.46% |
| 2013 | 5.00 | 40.08% |
| 2012 | 3.57 | -28.46% |
| 2011 | 4.98 | -38.91% |
| 2010 | 8.16 | -21.53% |
| 2009 | 10.40 | 15.36% |
| 2008 | 9.02 | -64.41% |
| 2007 | 25.33 | 92.70% |
| 2006 | 13.15 | 352.30% |
| 2005 | 2.91 | 11.39% |
| 2004 | 2.61 | -15.56% |
| 2003 | 3.09 | -18.48% |
| 2002 | 3.79 | -22.37% |
| 2001 | 4.88 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 10.02 | 134.64% |
US
|
|
| 40.55 | 849.38% |
US
|
|
| 4.19 | -1.88% |
AU
|
|
| 10.44 | 144.49% |
NL
|
|
| - | - |
CH
|
